 Home > Active Ingredient News > Drugs Articles > Notice on Publicly Soliciting Opinions on the "Technical Guidelines for the Design of Clinical Trials of Long-acting Granulocyte Colony Stimulating Factor Preventing Infection after Chemotherapy (Draft for Solicitation of Comments)"

Notice on Publicly Soliciting Opinions on the "Technical Guidelines for the Design of Clinical Trials of Long-acting Granulocyte Colony Stimulating Factor Preventing Infection after Chemotherapy (Draft for Solicitation of Comments)"

 Last Update: 2021-10-21
 Source: Internet
 Author: User

Tags

cns clinical trials

drug interaction calculator

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Neutropenia is a hematological toxicity related to bone marrow suppression caused by chemotherapy.
The degree and duration of its reduction are closely related to the risk of infection and even death
.

Recombinant human granulocyte colony stimulating factor (rhG-CSF) has been on the market for many years as an effective drug to prevent and treat neutropenia caused by tumor radiotherapy and chemotherapy

We sincerely welcome valuable comments and suggestions from all walks of life on the solicitation draft, and timely feedback to us for follow-up improvement
.

The time limit for soliciting opinions is 1 month from the date of publication

Please send your feedback to the mailbox of the following contact:

Contact: Zhang Hong

Contact: zhanghong@cde.

Thank you for your participation and great support

Drug Evaluation Center

October 11, 2021

Appendix:

1 "Long-acting Granulocyte Colony Stimulating Factor to Prevent Infection after Chemotherapy Clinical Trial Design Technical Guidelines (Draft for Solicitation of Comments)".

"Long-acting Granulocyte Colony Stimulating Factor to Prevent Infection after Chemotherapy Clinical Trial Design Technical Guidelines (Draft for Solicitation of Comments)".

"Technical Guidelines for the Design of Long-acting Granulocyte Colony Stimulating Factor to Prevent Infection after Chemotherapy (Draft for Comment)" Drafting Instructions.

"Long-acting Granulocyte Colony Stimulating Factor Clinical Trial Design Technical Guidelines for the Prevention of Infection after Chemotherapy (Draft for Solicitation of Comments)" feedback form for soliciting opinions.
docx

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Best Price Isopropylbenzylamine Crystal CAS 102-97-6 N-Isopropylbenzylamine Fast Delivery 99% crystal chemicals

CAS No.: 102-97-6

Pharmacy Grade

$2-2.2/MT EXW

Pregabalin Crystal CAS 148553-50-8 Lyrica Powder 99.0% White Powder Mobelbiochem

CAS No.: 148553-50-8

Pharmacy Grade

$35.00/KG FOB

PTD-DBM 99% freeze dried powder cas1199495-15-2

CAS No.: 1199495-15-2

Pharmacy Grade

$3-3.2/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.